600079 人福医药
已收盘 04-25 15:00:00
资讯
新帖
简况
控股股东、实控人变更!人福医药即将迎来“大换血”...
新浪财经 · 04-25 15:14
控股股东、实控人变更!人福医药即将迎来“大换血”...
人福医药:控股股东和实际控制人拟发生变更
澎湃新闻 · 04-25 12:28
人福医药:控股股东和实际控制人拟发生变更
人福医药:控股股东和实控人拟发生变更
E公司 · 04-25 12:18
人福医药:控股股东和实控人拟发生变更
人福医药:萘普生钠软胶囊获得药品注册证书
美港电讯 · 04-23
人福医药:萘普生钠软胶囊获得药品注册证书
人福医药04月22日主力净流入1626万元 散户资金抛售
市场透视 · 04-22
人福医药04月22日主力净流入1626万元 散户资金抛售
美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机
华尔街见闻 · 04-21
美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机
人福医药04月15日获主力加仓1740万元
市场透视 · 04-15
人福医药04月15日获主力加仓1740万元
人福医药(600079.SH):HW231019片获得药物临床试验批准通知书
智通财经网 · 03-11
人福医药(600079.SH):HW231019片获得药物临床试验批准通知书
人福医药03月10日主力净流入446万元 散户资金抛售
市场透视 · 03-10
人福医药03月10日主力净流入446万元 散户资金抛售
【重磅】人福医药抢攻150亿市场,首款1类新药来了
米内网 · 03-07
【重磅】人福医药抢攻150亿市场,首款1类新药来了
医疗健康行业2024年专利分析白皮书
知识产权出版社 · 03-06
医疗健康行业2024年专利分析白皮书
人福医药03月05日主力净流出2802万元 散户资金买入
市场透视 · 03-05
人福医药03月05日主力净流出2802万元 散户资金买入
人福医药03月04日主力净流入572万元 散户资金抛售
市场透视 · 03-04
人福医药03月04日主力净流入572万元 散户资金抛售
人福医药最新公告:控股子公司CXJM-66注射液获得药物临床试验批准通知书
证券之星 · 02-27
人福医药最新公告:控股子公司CXJM-66注射液获得药物临床试验批准通知书
人福医药(600079.SH)子公司宜昌人福盐酸他喷他多片获得药品注册证书
智通财经 · 02-26
人福医药(600079.SH)子公司宜昌人福盐酸他喷他多片获得药品注册证书
人福医药:控股子公司宜昌人福盐酸他喷他多片获批上市
每日经济新闻 · 02-26
人福医药:控股子公司宜昌人福盐酸他喷他多片获批上市
人福医药02月21日主力净流出9705万元 散户资金买入
市场透视 · 02-21
人福医药02月21日主力净流出9705万元 散户资金买入
加载更多
公司概况
公司名称:
人福医药集团股份公司
所属行业:
医药制造业
上市日期:
1997-06-06
主营业务:
人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械。公司是湖北省医药工业龙头企业和国家技术创新示范企业。公司连续14年入选国家工信部“中国医药工业百强榜”,入选“2023中国制造业企业500强”、“2023中国制造业民营企业500强”榜单。
发行价格:
5.22
{"stockData":{"symbol":"600079","market":"SH","secType":"STK","nameCN":"人福医药","latestPrice":20.24,"timestamp":1745564400000,"preClose":20.46,"halted":0,"volume":14133567,"delay":0,"changeRate":-0.0108,"floatShares":1543000000,"shares":1632000000,"eps":1.1981,"marketStatus":"已收盘","change":-0.22,"latestTime":"04-25 15:00:00","open":20.5,"high":20.52,"low":20.07,"amount":286000000,"amplitude":0.022,"askPrice":20.25,"askSize":49,"bidPrice":20.24,"bidSize":485,"shortable":0,"etf":0,"ttmEps":1.1981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745803800000},"marketStatusCode":5,"adr":0,"adjPreClose":20.46,"symbolType":"stock","openAndCloseTimeList":[[1745544600000,1745551800000],[1745557200000,1745564400000]],"highLimit":22.51,"lowLimit":18.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1632225965,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":16.893415,"roe":"9.02%","epsLYR":1.32,"committee":0.677868,"marketValue":33036000000,"turnoverRate":0.0092,"status":1,"floatMarketCap":31234000000},"requestUrl":"/m/hq/s/600079","defaultTab":"news","newsList":[{"id":"2530551911","title":"控股股东、实控人变更!人福医药即将迎来“大换血”...","url":"https://stock-news.laohu8.com/highlight/detail?id=2530551911","media":"新浪财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530551911?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:14","pubTimestamp":1745594048,"startTime":"0","endTime":"0","summary":"招商生科将合计控制人福医药3.87亿股股份,占总股本的23.70%,并享有相应表决权。届时,人福医药的控股股东将由当代科技变更为招商生科,实际控制人从艾路明变为招商局集团有限公司。随着公司易主,人福医药可能会迎来管理层变动。2022年3月,人福医药下属多家子公司向珂美立德购买物业资产,合同金额合计16.45亿元,当时人福医药明确否认与珂美立德存在关联关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523180394e2a113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523180394e2a113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0012","BK0070","BK0188","BK0185","600079","BK0096"],"gpt_icon":0},{"id":"2530807691","title":"人福医药:控股股东和实际控制人拟发生变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2530807691","media":"澎湃新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530807691?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:28","pubTimestamp":1745584080,"startTime":"0","endTime":"0","summary":"4月25日晚间,人福医药集团股份公司公告,公司近日收到控股股东武汉当代科技产业集团股份有限公司管理人发来的告知书,湖北省武汉市中级人民法院于2025年4月25日出具鄂01破22号之四《民事裁定书》,裁定批准《武汉当代科技产业集团股份有限公司重整计划》,并终止当代科技重整程序。本次权益变动属于执行司法裁定,不触及要约收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520290594e278b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520290594e278b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0096","600079","BK0012","BK0028","BK0188","BK0239","BK0185"],"gpt_icon":0},{"id":"2530818751","title":"人福医药:控股股东和实控人拟发生变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2530818751","media":"E公司","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530818751?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:18","pubTimestamp":1745583488,"startTime":"0","endTime":"0","summary":"人民财讯4月25日电,人福医药(600079)4月25日晚间公告,公司近日收到控股股东武汉当代科技产业集团股份有限公司(简称“当代科技”)管理人发来的告知书,湖北省武汉市中级人民法院于2025年4月25日出具《民事裁定书》,裁定批准当代科技重整计划,并终止当代科技重整程序。根据当代科技重整计划,重整投资人招商局创新科技(集团)有限公司设立全资子公司招商生科参与当代科技重整,投资总额为118亿元。重整计划实施完成后,招商生科将合计控制公司3.87亿股股份、占公司总股本23.70%对应的表决权。公司控股股东将有可能由当代科技变更为招商生科,公司实际控制人将有可能由艾路明变更为招商局集团有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520180894e2759f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520180894e2759f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0239","600079","BK0070","BK0028","BK0188","BK0185","BK0012"],"gpt_icon":0},{"id":"2529152497","title":"人福医药:萘普生钠软胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2529152497","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529152497?lang=zh_cn&edition=full","pubTime":"2025-04-23 16:46","pubTimestamp":1745397977,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0096","BK0012","BK0185","600079","BK0188","BK0028","BK0070","BK0239"],"gpt_icon":0},{"id":"2529345196","title":"人福医药04月22日主力净流入1626万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529345196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529345196?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:18","pubTimestamp":1745306319,"startTime":"0","endTime":"0","summary":"04月22日, 人福医药股价涨0.43%,报收20.85元,成交金额2.29亿元,换手率0.71%,振幅2.02%,量比0.97。人福医药今日主力资金净流入1626万元,上一交易日主力净流出1840万元。该股近5个交易日下跌0.24%,主力资金累计净流出273万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出9818万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422153301a6c369ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422153301a6c369ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","BK0185","BK0188","600079","BK0070","BK0096","BK0012"],"gpt_icon":0},{"id":"2529809163","title":"美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809163","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809163?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:06","pubTimestamp":1745230017,"startTime":"0","endTime":"0","summary":"特朗普口中的“关税武器”,瞄准了全球仰赖的仿制药供应链。据央视新闻,美国或对进口药品征收关税。特朗普多次放话,药品可能被纳入征税范围。本周,美国商务部也宣布对药品进口是否构成“国家安全风险”启动调查。要知道,仿制药承担了美国约90%的药品供应,本身利润就极其微薄,加征关税一旦成真,部分药企或直接停产。目前美国大部分仿制药产自印度和东南亚,美国很难自给自足。事实上,美国药品供应紧张早已有苗头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600624","600267","600276","600789","688758","688566","688076","600613","BK0239","688321","688578","600079","603669","688506","603538","600664","603811","600774","688247","603168","688166","688513","688356","603676","603207","603229","600521","688799","605116","603351","600812","603707"],"gpt_icon":0},{"id":"2527330454","title":"人福医药04月15日获主力加仓1740万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527330454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527330454?lang=zh_cn&edition=full","pubTime":"2025-04-15 15:18","pubTimestamp":1744701534,"startTime":"0","endTime":"0","summary":"04月15日, 人福医药股价涨1.31%,报收20.90元,成交金额3.25亿元,换手率1.01%,振幅3.54%,量比0.76。人福医药今日主力资金净流入1740万元,上一交易日主力净流入1536万元。该股近5个交易日上涨3.72%,主力资金累计净流出2442万元;近20日主力资金累计净流出7645万元,其中净流出天数为13日。该股主力净额占比0.05%,A股市场排名1067/5410,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415154257a45963ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415154257a45963ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","600079","BK0185","BK0028","BK0188","BK0239","BK0070","BK0096"],"gpt_icon":0},{"id":"2518972587","title":"人福医药(600079.SH):HW231019片获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518972587","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518972587?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:37","pubTimestamp":1741682220,"startTime":"0","endTime":"0","summary":"人福医药(600079.SH)发布公告,公司控股子公司宜昌人福药业有限责任公司(以下简称“宜昌人福”,公司持有其80%的股权)近日收到国家药品监督管理局核准签发的HW231019片《药物临床试验批准通知书》,同意本品开展“用于急性疼痛的治疗”适应症的临床试验。HW231019为宜昌人福研发的新分子实体。HW231019片临床上拟用于急性疼痛的治疗。国内目前尚无同类型产品获批上市。截至目前,宜昌人福在该项目上的累计研发投入约为2,000万元人民币。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-11/doc-inephnhp2653486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","03347","BK1583","BK0096","BK1576","BK0028","BK0070","BK0239","600079","BK0012","BK0185","BK1141"],"gpt_icon":0},{"id":"2518990652","title":"人福医药03月10日主力净流入446万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518990652","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518990652?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:18","pubTimestamp":1741591132,"startTime":"0","endTime":"0","summary":"03月10日, 人福医药股价涨0.55%,报收20.00元,成交金额2.68亿元,换手率0.87%,振幅1.56%,量比0.85。人福医药今日主力资金净流入446万元,上一交易日主力净流出5005万元。该股近5个交易日下跌0.40%,主力资金累计净流出6743万元;近20日主力资金累计净流出4.51亿元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310153614a26990cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310153614a26990cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","600079","BK0070","BK0012","BK0185","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2517434867","title":"【重磅】人福医药抢攻150亿市场,首款1类新药来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2517434867","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517434867?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:45","pubTimestamp":1741337130,"startTime":"0","endTime":"0","summary":"精彩内容近日,人福医药旗下武汉人福创新药物研发中心的1类新药HW201877胶囊获批临床,适应症为炎症性肠病。2023年在中国三大终端六大市场,止泻药及肠道抗炎/抗感染药(化+生)的市场规模超过150亿元,该新药是人福医药在该亚类市场首款1类新药,值得期待。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307230357abed534f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307230357abed534f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0028","BK0188","600079","BK0012","BK0239","BK0185","BK0096"],"gpt_icon":0},{"id":"2517046438","title":"医疗健康行业2024年专利分析白皮书","url":"https://stock-news.laohu8.com/highlight/detail?id=2517046438","media":"知识产权出版社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517046438?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:00","pubTimestamp":1741276800,"startTime":"0","endTime":"0","summary":"本报告从医疗健康行业全球专利竞争态势、支撑技术和业务应用场景等维度进行分析,以期全面了解医疗健康行业专利竞争发展现状。中国医疗健康行业的专利申请数量已超过18.7 万件,占全球总量的51.7%,远超过其他国家。平安集团以4176 件医疗健康行业专利申请位居第一位,飞利浦以微弱差距位居第二,两家企业专利申请量远超其他专利权人,专利优势突出,技术创新实力明显超过其他主体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307200225a26426e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307200225a26426e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688617","BK0012","600079","600521","688315","603259","600566","603127","688621","LU2328871848.SGD","600196","600763","BK0060","BK0188","LU1328615791.USD","688073","LU1969619763.USD","600085","688710","LU1064131003.USD","603456","BK0183","600332","688578","159760","LU2148510915.USD","688271","603087","600436","688238","688265","688046","LU0405327494.USD","LU0405327148.USD","603882","688131","688278","LU1064130708.USD","603658","600568","600380","600721","688202","600161","LU2488822045.USD","BK0028","600276","BK0239","688222","BK0196"],"gpt_icon":0},{"id":"2517696906","title":"人福医药03月05日主力净流出2802万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517696906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517696906?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:18","pubTimestamp":1741159127,"startTime":"0","endTime":"0","summary":"03月05日, 人福医药股价跌0.65%,报收19.97元,成交金额2.34亿元,换手率0.76%,振幅1.94%,量比0.59。人福医药今日主力资金净流出2802万元,上一交易日主力净流入572万元。该股近5个交易日上涨1.01%,主力资金累计净流出6128万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出3.66亿元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305153339abe91c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305153339abe91c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0239","600079","BK0070","BK0028","BK0188","BK0185","BK0012"],"gpt_icon":0},{"id":"2516646356","title":"人福医药03月04日主力净流入572万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516646356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516646356?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:18","pubTimestamp":1741072686,"startTime":"0","endTime":"0","summary":"03月04日, 人福医药股价涨0.10%,报收20.10元,成交金额2.15亿元,换手率0.69%,振幅2.09%,量比0.45。人福医药今日主力资金净流入572万元,上一交易日主力净流出16万元。该股近5个交易日上涨2.97%,主力资金累计净流出3963万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出3.14亿元,其中净流出天数为11日。该股主力净额占比0.02%,A股市场排名1661/5685,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304152624a25e6de6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304152624a25e6de6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0028","BK0185","BK0096","BK0012","600079","BK0188","BK0239"],"gpt_icon":0},{"id":"2514262878","title":"人福医药最新公告:控股子公司CXJM-66注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514262878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514262878?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:08","pubTimestamp":1740647327,"startTime":"0","endTime":"0","summary":"人福医药公告称,公司控股子公司宜昌人福药业有限责任公司收到国家药品监督管理局核准签发的CXJM-66注射液《药物临床试验批准通知书》,同意开展用于手术麻醉和术后镇痛的临床研究。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700029340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","600079","BK1576","BK0096","BK0028","03347","BK0070","BK1141","BK0012","BK1583","BK0188","BK0239"],"gpt_icon":0},{"id":"2514885758","title":"人福医药(600079.SH)子公司宜昌人福盐酸他喷他多片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885758","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885758?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:47","pubTimestamp":1740559639,"startTime":"0","endTime":"0","summary":"智通财经APP讯,人福医药(600079.SH)公告,公司控股子公司宜昌人福药业有限责任公司(简称“宜昌人福”,公司持有其80%的股权)近日收到国家药品监督管理局核准签发的盐酸他喷他多片的《药品注册证书》。据悉,盐酸他喷他多片适用于治疗成人患者需要使用阿片类药物治疗且替代治疗不能充分缓解的急性疼痛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0070","BK0185","BK0096","BK0239","BK0028","BK0188","600079"],"gpt_icon":0},{"id":"2514355885","title":"人福医药:控股子公司宜昌人福盐酸他喷他多片获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2514355885","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514355885?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:41","pubTimestamp":1740559260,"startTime":"0","endTime":"0","summary":"每经AI快讯,2月26日,人福医药公告称,公司控股子公司宜昌人福药业有限责任公司收到国家药品监督管理局核准签发的盐酸他喷他多片的《药品注册证书》。该药品适用于治疗成人患者需要使用阿片类药物治疗且替代治疗不能充分缓解的急性疼痛,目前未在国内上市。宜昌人福于2023年9月提交上市许可申请并获得受理,累计研发投入约为5,500万元人民币。本次获批标志着宜昌人福具备了在国内市场生产销售该药品的资格,进一步丰富了公司的产品线。但该产品未来的具体销售情况可能受到行业政策、市场环境等因素影响,具有不确定性。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261646309893553f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261646309893553f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0096","BK0028","BK0012","BK0070","BK0239","600079","BK0185"],"gpt_icon":0},{"id":"2513253265","title":"人福医药02月21日主力净流出9705万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2513253265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513253265?lang=zh_cn&edition=full","pubTime":"2025-02-21 15:20","pubTimestamp":1740122413,"startTime":"0","endTime":"0","summary":"02月21日, 人福医药股价跌2.35%,报收19.97元,成交金额6.44亿元,换手率2.08%,振幅3.18%,量比1.17。人福医药今日主力资金净流出9705万元,上一交易日主力净流入2172万元。该股近5个交易日下跌2.63%,主力资金累计净流出1.86亿元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出2.84亿元,其中净流出天数为9日。该股主力净额占比0.31%,A股市场排名4892/5000,低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221153303abd7394d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221153303abd7394d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0096","600079","BK0188","BK0239","BK0185","BK0012","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745795842596,"stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":0.0156},{"period":"3month","weight":-0.0754},{"period":"6month","weight":-0.0608},{"period":"1year","weight":0.0084},{"period":"ytd","weight":-0.1343}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.0793},{"period":"ytd","weight":-0.0169}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"人福医药集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41834人(较上一季度减少11.45%)","perCapita":"36888股","listingDate":"1997-06-06","address":"湖北省武汉市洪山区东湖高新区高新大道666号","registeredCapital":"163222万元","survey":" 人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械。公司是湖北省医药工业龙头企业和国家技术创新示范企业。公司连续14年入选国家工信部“中国医药工业百强榜”,入选“2023中国制造业企业500强”、“2023中国制造业民营企业500强”榜单。","listedPrice":5.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"人福医药,600079,人福医药股票,人福医药股票老虎,人福医药股票老虎国际,人福医药行情,人福医药股票行情,人福医药股价,人福医药股市,人福医药股票价格,人福医药股票交易,人福医药股票购买,人福医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}